Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.

Pradhan P, Upadhyay N, Tiwari A, Singh LP.

New Front Ophthalmol. 2016;2(5):192-204. doi: 10.15761/NFO.1000145. Epub 2016 Oct 24.

2.

Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.

Sato S, Shinoda H, Nagai N, Suzuki M, Uchida A, Kurihara T, Kamoshita M, Tomita Y, Iyama C, Minami S, Yuki K, Tsubota K, Ozawa Y.

Medicine (Baltimore). 2017 Apr;96(16):e6459. doi: 10.1097/MD.0000000000006459.

3.

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

LeBlanc ME, Wang W, Chen X, Caberoy NB, Guo F, Shen C, Ji Y, Tian H, Wang H, Chen R, Li W.

J Exp Med. 2017 Apr 3;214(4):1029-1047. doi: 10.1084/jem.20161802. Epub 2017 Mar 22.

PMID:
28330905
4.

Angiogenesis in the atherosclerotic plaque.

Camaré C, Pucelle M, Nègre-Salvayre A, Salvayre R.

Redox Biol. 2017 Aug;12:18-34. doi: 10.1016/j.redox.2017.01.007. Epub 2017 Feb 1. Review.

5.

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.

Hendry SA, Farnsworth RH, Solomon B, Achen MG, Stacker SA, Fox SB.

Front Immunol. 2016 Dec 20;7:621. doi: 10.3389/fimmu.2016.00621. eCollection 2016. Review.

6.

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.

Andrés-Guerrero V, Perucho-González L, García-Feijoo J, Morales-Fernández L, Saenz-Francés F, Herrero-Vanrell R, Júlvez LP, Llorens VP, Martínez-de-la-Casa JM, Konstas AG.

Adv Ther. 2017 Feb;34(2):378-395. doi: 10.1007/s12325-016-0461-z. Epub 2016 Dec 20. Review.

7.

Chemotherapeutic potentials of the stem bark of Balanite aegyptiaca (L.) Delile: an antiangiogenic, antitumor and antioxidant agent.

Hassan LE, Dahham SS, Saghir SA, Mohammed AM, Eltayeb NM, Majid AM, Majid AS.

BMC Complement Altern Med. 2016 Oct 19;16(1):396.

8.

Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.

Vähätupa M, Prince S, Vataja S, Mertimo T, Kataja M, Kinnunen K, Marjomäki V, Uusitalo H, Komatsu M, Järvinen TA, Uusitalo-Järvinen H.

Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4898-4909. doi: 10.1167/iovs.16-19212.

9.

Nanomedicine: Addressing Cardiovascular Disease and Cardiovascular Tissue Regeneration.

Neal RA, Oredein-McCoy O, Botchwey EA.

Curr Bioact Compd. 2009;5(3):206-214.

10.

Subclinical Pregnancy Toxemia-Induced Gene Expression Changes in Ovine Placenta and Uterus.

Kasimanickam RK.

Front Vet Sci. 2016 Aug 30;3:69. doi: 10.3389/fvets.2016.00069. eCollection 2016.

11.

Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.

Bolinger MT, Antonetti DA.

Int J Mol Sci. 2016 Sep 7;17(9). pii: E1498. doi: 10.3390/ijms17091498. Review.

12.

The role of the semaphorins in cancer.

Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O.

Cell Adh Migr. 2016 Nov;10(6):652-674. Epub 2016 Aug 17. Review.

PMID:
27533782
13.

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.

Morfoisse F, Renaud E, Hantelys F, Prats AC, Garmy-Susini B.

Mol Cell Oncol. 2015 May 27;2(4):e1024821. doi: 10.1080/23723556.2015.1024821. eCollection 2015 Oct-Dec. Review.

14.

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.

Morfoisse F, Renaud E, Hantelys F, Prats AC, Garmy-Susini B.

Mol Cell Oncol. 2014 Aug 13;1(1):e29907. doi: 10.4161/mco.29907. eCollection 2014. Review.

15.

Flt1/VEGFR1 heterozygosity causes transient embryonic edema.

Otowa Y, Moriwaki K, Sano K, Shirakabe M, Yonemura S, Shibuya M, Rossant J, Suda T, Kakeji Y, Hirashima M.

Sci Rep. 2016 Jun 2;6:27186. doi: 10.1038/srep27186.

16.

Fine processes of Nestin-GFP-positive radial glia-like stem cells in the adult dentate gyrus ensheathe local synapses and vasculature.

Moss J, Gebara E, Bushong EA, Sánchez-Pascual I, O'Laoi R, El M'Ghari I, Kocher-Braissant J, Ellisman MH, Toni N.

Proc Natl Acad Sci U S A. 2016 May 3;113(18):E2536-45. doi: 10.1073/pnas.1514652113. Epub 2016 Apr 18.

17.

Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery.

Xing C, Lo EH.

Prog Neurobiol. 2017 May;152:181-199. doi: 10.1016/j.pneurobio.2016.04.004. Epub 2016 Apr 11. Review.

PMID:
27079786
18.

Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.

Kong BS, Im SJ, Lee YJ, Cho YH, Do YR, Byun JW, Ku CR, Lee EJ.

PLoS One. 2016 Mar 22;11(3):e0149394. doi: 10.1371/journal.pone.0149394. eCollection 2016.

19.

Vascular endothelial growth factor from embryonic status to cardiovascular pathology.

Azimi-Nezhad M.

Rep Biochem Mol Biol. 2014 Apr;2(2):59-69. Review.

20.

VEGF and Intraocular Neovascularization: From Discovery to Therapy.

Ferrara N.

Transl Vis Sci Technol. 2016 Mar 11;5(2):10. eCollection 2016 Mar.

Supplemental Content

Support Center